#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2056	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2428	250.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1796	1796	T	314	T	268	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2056	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2428	250.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1530	1530	C	329	C	263	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2056	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2428	250.1	0	HET	.	.	.	A69G	.	69	69	A	415	415	A	289	A,G	181,55	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3522	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3897	270.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1824	1824	A	279	A	232	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3522	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3897	270.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2458	2458	C	355	C,T,A	284,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3522	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3897	270.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2532	2532	A	360	A	294	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3522	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3897	270.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3084	3084	C	288	C,A	228,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	292	folP	852	852	99.88	folP.l6.c17.ctg.1	1885	46.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	992	994	AAA	70;68;68	A;A;A	56;55;55	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	292	folP	852	852	99.88	folP.l6.c17.ctg.1	1885	46.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1223	1225	AGC	59;59;59	A,C;G;C	44,1;46;47	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	612	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3671	49.7	1	SNP	p	S91F	0	.	.	271	273	TCC	732	734	TCC	45;45;45	T;C;C	34;41;41	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	612	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3671	49.7	1	SNP	p	D95N	0	.	.	283	285	GAC	744	746	GAC	46;46;46	G;A;C	40;40;38	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	612	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3671	49.7	1	SNP	p	D95G	0	.	.	283	285	GAC	744	746	GAC	46;46;46	G;A;C	40;40;38	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	386	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1448	78.6	1	SNP	p	G45D	0	.	.	133	135	GGC	563	565	GGC	121;121;121	G;G;C	99;99;98	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	188	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1324	42.3	0	.	n	.	0	A197.	DEL	197	197	A	738	738	A	87	A	71	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	666	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3248	61.3	1	SNP	p	D86N	0	.	.	256	258	GAC	724	726	GAC	77;77;77	G;A;C	65;64;67	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	666	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3248	61.3	1	SNP	p	S87W	0	.	.	259	261	AGT	727	729	AGT	78;78;77	A,C;G;T	61,1;64;66	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	666	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3248	61.3	1	SNP	p	S87R	0	.	.	259	261	AGT	727	729	AGT	78;78;77	A,C;G;T	61,1;64;66	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	666	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3248	61.3	1	SNP	p	S87I	0	.	.	259	261	AGT	727	729	AGT	78;78;77	A,C;G;T	61,1;64;66	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	666	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3248	61.3	1	SNP	p	S88P	0	.	.	262	264	TCC	730	732	TCC	77;76;76	T;C,G;C	65;65,1;64	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	644	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3022	63.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1718	1720	GGC	94;94;93	G;G;C	80;76;81	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1318	1320	GCA	92;92;92	G,T;C,A;A	74,1;70,1;76	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1321	1323	ATC	93;94;94	A;T;C	76;75;76	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1333	1335	GTG	92;91;91	G;T;G,T	73;71;73,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1333	1335	GTG	92;91;91	G;T;G,T	73;71;73,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1837	1839	ACC	61;61;60	A;C;C	51;53;52	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1891	1893	GCG	62;61;60	G;C;G	51;44;46	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1891	1893	GCG	62;61;60	G;C;G	51;44;46	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2014	2016	GGC	61;60;60	G;G;C	43;42;46	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2023	2025	GGC	61;61;60	G;G,C;C,G	41;41,1;41,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	540	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2583	62.4	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2041	2043	CTG	62;62;63	C;T,G;G	44;48,1;47	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	742	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3364	65.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1813	1815	CCG	51;52;51	C;C;G	40;42;43	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	324	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2053	47.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	615	615	C	34	C	31	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1048	1050	AAT	2;2;2	A;A;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1051	1053	AAT	2;2;2	A;A;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1075	1077	GCA	2;2;2	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1098	1100	GTA	2;2;2	G;T;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1104	1106	AAC	2;2;2	A;A;C	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1108	1112	TGGCG	2;2;2;2;2	T;G;G;C;G	1;1;1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1114	1116	GCT	2;2;2	G;C;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1174	1176	TTA	1;1;1	T;T;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1219	1221	CAT	1;1;1	C;A;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1222	1224	AGT	1;1;1	A;G;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	48	porB1a	984	294	90.27	porB1a.l15.c4.ctg.1	1317	10.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1231	1233	TAC	1;1;1	T;A;C	1;1;1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	430	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1844	69.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	524	526	GAA	90;90;89	G;A;A	75;78;75	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	430	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1844	69.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	812	814	GAT	75;75;75	G;A;T	60;61;58	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	430	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1844	69.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	935	937	TCA	86;86;86	T;C;A	67;71;69	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	430	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1844	69.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1064	1066	GTC	96;96;95	G;T;C	86;80;83	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	430	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1844	69.1	1	SNP	p	G120K	1	.	.	358	360	AAG	770	772	AAG	82;82;82	A;A,C;G	68;66,1;66	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	430	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1844	69.1	1	SNP	p	A121D	1	.	.	361	363	GAC	773	775	GAC	83;84;84	G;A;C	69;70;69	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	430	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1844	69.1	1	SNP	p	D121N	0	.	.	361	363	GAC	773	775	GAC	83;84;84	G;A;C	69;70;69	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	116	92.24	porB3.l6.c30.ctg.1	1063	13.3	0	.	p	.	0	M18T	NONSYN	52	54	ATG	984	986	ACG	17;17;17	A;C;G	10;10;11	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	116	92.24	porB3.l6.c30.ctg.1	1063	13.3	0	.	p	.	0	T29A	NONSYN	85	87	ACC	1017	1019	GCC	12;11;11	G;C;C	10;8;9	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	116	92.24	porB3.l6.c30.ctg.1	1063	13.3	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	1026	1028	CAA	11;11;11	C;A;A	9;9;9	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	116	92.24	porB3.l6.c30.ctg.1	1063	13.3	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	1032	1034	TAC	9;8;8	T;A;C	8;7;8	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1604	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5214	92.1	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2240	2242	AAT	85;85;85	A;A;T,C	73;72;71,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	238	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1421	50.2	1	SNP	p	V57M	1	.	.	169	171	ATG	755	757	ATG	96;96;96	A;T;G,T	77;77;75,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
